• Home
  1. Home
  2. Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years
Scientific article
English

Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years

ContributorsFerrari, Serge Livio; Adachi, J. D.; Lippuner, K.; Zapalowski, C.; Miller, P. D.; Reginster, J.-Y.; Törring, O.; Kendler, D. L.; Daizadeh, N. S.; Wang, A.; O'Malley, C. D.; Wagman, R. B.; Libanati, C.; Lewiecki, E. M.
Published inOsteoporosis international, vol. 26, no. 12, p. 2763-2771
Publication date2015
Affiliation entities
Research groups
Citation (ISO format)
FERRARI, Serge Livio et al. Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years. In: Osteoporosis international, 2015, vol. 26, n° 12, p. 2763–2771. doi: 10.1007/s00198-015-3179-x
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Additional URL for this publicationhttp://link.springer.com/10.1007/s00198-015-3179-x
Journal ISSN0937-941X
536views
0downloads

Technical informations

Creation12/02/2015 4:02:00 PM
First validation12/02/2015 4:02:00 PM
Update time03/15/2023 12:02:25 AM
Status update03/15/2023 12:02:24 AM
Last indexation10/31/2024 2:27:17 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack